04:56 PM EDT, 03/13/2024 (MT Newswires) -- J Mariner Kemper, Director, Chairman and CEO, on March 12, 2024, sold 8,280 shares in Umb Financial ( UMBF ) for $662,801. Following the Form 4 filing with the SEC, Kemper has control over a total of 2,762,384 shares of the company, with 257,796 shares held directly and 2,504,587 controlled indirectly. SEC Filing:...

04:55 PM EDT, 03/13/2024 (MT Newswires) -- J Mariner Kemper, Director, Chairman and CEO, on March 12, 2024, sold 7,920 shares in Umb Financial ( UMBF ) for $636,505. Following the Form 4 filing with the SEC, Kemper has control over a total of 2,754,464 shares of the company, with 257,796 shares held directly and 2,496,667 controlled indirectly. SEC Filing:...

04:56 PM EDT, 03/13/2024 (MT Newswires) -- Laurence N Charney, Director, on March 12, 2024, sold 22,000 shares in Tg Therapeutics ( TGTX ) for $351,340. Following the Form 4 filing with the SEC, Charney has control over a total of 215,229 shares of the company, with 215,229 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1001316/000143774924007662/xslF345X03/rdgdoc.xml Price: 15.75, Change: +0.02, Percent Change:...

04:55 PM EDT, 03/13/2024 (MT Newswires) -- 10x Genomics ( TXG ) said Wednesday it started shipping two new products, Chromium Single Cell Gene Expression 3' v4 and Chromium Single Cell Immune Profiling 5' v3. Both products are powered by GEM-X technology architecture, according to the company. 10x shares were up 2.6% in recent after-hours activity. Price: 39.52, Change: +1,...